Overview

Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
A double-blind, active-controlled, randomized trial to compare Valsartan plus Hydrochlorothiazide 80mg/12.5mg and Amlodipine 5 mg. Study design: 2 weeks washout, 8 weeks treatment period.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Hydrochlorothiazide
Valsartan